Burnham Institute Selects Labcyte Acoustic Liquid Handling Technology
16 Nov 2007Labcyte Inc. will supply Burnham Institute for Medical Research (Burnham) with more than $2.3 million worth of Echo® liquid handlers for use in screening large biological libraries. The systems will be installed at both the Institute’s LaJolla, (CA) and Lake Nona, Orlando (FL) campuses. These instruments will be part of the world’s largest screening system and will bolster Burnham’s research and drug discovery efforts, which include research on cancer, neurological diseases, aging, diabetes, and obesity.
Burnham is one of the nation’s 10 collaborating centers of excellence funded under a special initiative created by the National Institutes of Health, which together comprise the largest public-sector drug discovery effort in history. The state-of-the-art Labcyte technology will improve screening results while reducing operating costs for Burnham and the collaborating network advancing this historical effort. The systems will be delivered over the next six months.
“The Echo liquid handlers were selected because their unique acoustic technology will enhance our ability to miniaturize assays, reduce compound waste, and meet throughput requirements,” explained Dr. Stefan Vasile, Director of the Chemical Library Screening Facility for Burnham Institute. “The Echo systems will be used for compound plate-to-plate transfer, reformatting, dose-response experiments and hit picking.”
“Our patented acoustic droplet ejection technology dramatically reduces waste while cutting operating expenses,” said Dr. Elaine J. Heron, Labcyte CEO. “Traditional liquid handlers are prone to poor precision and accuracy as transfer volumes are decreased. Researchers who require flexibility in their processes and biology find that the Echo systems provide that for them easily, quickly, and cost-effectively.”